The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit
later.
We apologize for any inconvenience caused
Clinical Study of 125 Ⅰ Radioactive Particles Implanted to Treat Hilar Cholangiocarcinoma
Author(s): CUI Xin-jiang, CAO Gui-wen, NING Hou-fa, WANG Xiu-chun, SUN Shun-ji, SUN Li-ning, SUN Lu
Pages: 289-
292
Year: 2008
Issue:
4
Journal: ACTA ACADEMIAE MEDICINAE WEIFANG
Keyword: 125Ⅰ放射性粒子; PTCD; 肝门部胆管癌;
Abstract: 目的 观察125 Ⅰ放射性粒子对肝门部胆管癌的临床治疗效果.方法 78例肝门部胆管癌患者随机分成3组,A组经皮经肝胆管引流术(PTCD)27例、B组(125 Ⅰ粒子)39例及C组(PTCD+125 Ⅰ粒子)12例,通过观察术前术后总胆红素的改变、肿瘤大小的变化及患者的生存率,分析125 Ⅰ放射性粒子永久性植入治疗胆管癌的疗效.结果 术后半个月,A,B,C 3组总胆红素下降率分别为81.5%(22/27),66.7%(26/39),83.3%(10/12),A,B两组及B,C两组差异均有显著性(P<0.05);术后1年3组(CR+PR)分别为29.6%(8/27),74.4%(29/39),75.0%(9/12),A,B两组及A,C两组差异均有显著性(P<0.05);术后6个月和12个月生存率,B组为89.7%,82.1%,C组为91.7%,83.3%,明显高于A组的59.3%,33.3%(P<0.05).结论 对肝门部胆管癌,125 Ⅰ放射性粒子有治疗作用,PTCD术为姑息性治疗,125 Ⅰ放射性粒子联合PTCD术可取得更佳效果.
Citations
No citation found